Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells


Momentum Fellow (2020-Present)

Kriti Bahl, PhD, University of California, San Francisco

Dr. Bahl is investigating how the RasGRP1-mTORC1 pathway leads to an altered metabolic state in naïve T cells and how it functions in leukemia and other cancer types.

BACK TO OUR PORTFOLIO